RenovoRx RNXT
NASDAQ RNXT
$1.77 -0.23 (-11.28%)
At close: Sep 10, 2026 · 4:00 PM EDT

RenovoRx (RNXT) Receivables (2024 - 2026)

RenovoRx's (RNXT) quarterly Receivables came in at $480000.0 in Q2 2026, up 32.23% year-over-year from $363000.0 in Q2 2025, and up 71.43% quarter-over-quarter from $280000.0 in Q1 2026.

Analysis

RenovoRx (RNXT) Receivables (2024 - 2026) Analysis & Trends

RenovoRx has disclosed Receivables across 3 years of filings, most recently posting $480000.0 for Q2 2026.

  • In Q2 2026, Receivables rose 32.23% year-over-year to $480000.0; the TTM figure through Jun 2026 stood at $480000.0 (up 32.23% YoY), while the FY2025 annual figure was $139000.0, up 223.26% from the prior year.
  • Receivables came in at $480000.0 for Q2 2026 at RenovoRx, up from $280000.0 in the prior quarter.
  • In the past five years, Receivables ranged from a high of $480000.0 in Q2 2026 to a low of $43000.0 in Q4 2024.
  • Average Receivables over 3 years is $245142.9, with a median of $242000.0 recorded in 2025.
  • Year-over-year, Receivables soared 223.26% in 2025 and rose 15.7% in 2026.
  • Over 3 years, Receivables stood at $43000.0 in 2024, then soared by 223.26% to $139000.0 in 2025, then jumped by 245.32% to $480000.0 in 2026.
  • Per Business Quant data, the three most recent Receivables figures were $480000.0 in Q2 2026, $280000.0 in Q1 2026, and $139000.0 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Abbott Laboratories 179.79 Bn 174.18 Bn 7.27 Bn 8.60 Bn
2 Intuitive Surgical 127.69 Bn 122.47 Bn 1.96 Bn 1.67 Bn
3 Medtronic 117.23 Bn 108.41 Bn 6.34 Bn 6.36 Bn
4 Stryker 103.55 Bn 100.07 Bn 4.50 Bn 3.74 Bn
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn 3.18 Bn
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn 955.70 Mn
7 Alcon 32.83 Bn 31.37 Bn 1.68 Bn 2.08 Bn
8 Dexcom 32.30 Bn 30.35 Bn 830.00 Mn 1.28 Bn
9 Steris 20.73 Bn 20.25 Bn 684.20 Mn 1.01 Bn
10 RenovoRx 83.48 Mn 83.48 Mn 766,000.00 480,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 480,000.00
Mar 31, 2026 280,000.00
Dec 31, 2025 139,000.00
Sep 30, 2025 169,000.00
Jun 30, 2025 363,000.00
Mar 31, 2025 242,000.00
Dec 31, 2024 43,000.00